: inherit;">Young Amber, Moles Victor M, Jaafar Sara et al.
JAHA: Gender differences in the prognosis of ischemic stroke in patients with pulmonary hypertension
Time of Update: 2021-03-21
Researchers aimed to clarify the relationship between PH and poor hospitalization outcomes after acute ischemic stroke, and whether there are gender differences in this correlation.
Pulmonary hypertension market domestic drug rise the status of the original research drug is difficult to protect
Time of Update: 2021-02-28
On February 6, 2020, the State Drug Administration approved Pfizer's Sidina non-tablet (20 mg) for the treatment of pulmonary hypertension, the commodity name Rivanto.
GlaxoSmithKline pulmonary hypertension drug Volibris enlargement adaptation has been approved by the European Union
Time of Update: 2021-02-13
December 1, 2015 - British pharmaceutical giant GlaxoSmithKline (GSK) recently announced that the European Commission (EC) has approved the expansion of Volibris (ambrisentan, Ambersontan) current therapeutic adaptation to include combination therapy for the treatment of patients with pulmonary hypertension (PAH).
Expect pulmonary hypertension patients to "take fewer detours"
Time of Update: 2021-01-12
patients usually need to transfer multiple departments, multiple places to be finally diagnosed. and even after diagnosis, the treatment and follow-up management of PH patients is not optimistic. For example, without a right heart
A new strategy for pulmonary hypertension treatment is proposed
Time of Update: 2020-12-28
, and proposed a new treatment strategy for targeting vascular reconstruction to treat pulmonary hypertension. The paper was published in Nature -Newsletter. pulmonary hypertension is a serious threat to the life of patients cardiovascular disease
Gene Therapy Techniques for the Delivery of Endothelial Nitric Oxide Synthase to the Lung for Pulmonary Hypertension
Time of Update: 2020-12-17
Nitric oxide (NO) is synthesized by endothelial nitric oxide synthase (eNOS) and is important in regulating vascular resistance and in vascular remodeling in the lung.
Gene Therapy Techniques for the Delivery of Endothelial Nitric Oxide Synthase to the Corpora Cavernosa for Erectile Dysfunction
Time of Update: 2020-12-02
NO is synthesized by endothelial nitric oxide synthase (eNOS) and neuronal NOS (nNOS) in the penis.
Superoxide Dismutase A Target for Gene Therapeutic Approach to Reduce Oxidative Stress in Erectile Dysfunction
Time of Update: 2020-11-28
Erectile dysfunction (ED) is defined as the inability to attain and/or maintain penile erection sufficient for satisfactory sexual performance. Oxidative stress has been demonstrated to be involved in the pathophysiology of age
Zhengda Qing pulmonary artery hypertensive drug "Maxitentan tablets" first imitation is about to be approved.
Time of Update: 2020-10-12
(Source: Pharmaceutical Intelligence Data) Two competing for the first imitation so far, a total of two domestic Zhengda Qing, Xuantai two submitted to the market application for the maxitentan tablet generic drug.
"Pharmaceutical Speed Reading Society" is day clear pulmonary artery hypertensive drug maxitentan tablets first imitation is about to be approved.
Time of Update: 2020-10-08
, but the difference in efficacy this time was not statistically significant. (Sina Pharmaceutical News) Reding Pharmaceutical PARP inhibitors can reduce the risk of disease progression or death by 68% at the recent ESMO online conference
OCC 2020 Hydroxychloroquine's role in immunologic disease-related pulmonary hypertension and its value in neocoopha?
Time of Update: 2020-10-03
Pulmonary Arterial Hypertension and The Value of Coronary Pneumonia". Mengtao Li, a professor of treatment options for SLE-PAH underlying diseases, an important concept in SLE-PAH treatment is "standard therapy". consensus recommends "double
Erectile dysfunction and premature ejaculation drugs are collected male friends are blessed?
Time of Update: 2020-09-09
data show that in 2019, the total domestic sales of these three PDE-5 inhibitors exceeded 3.3 billion yuan, a total growth rate of more than 8%.
Hypertension: Predictive value of pulmonary arterial compliance in patients with systemic lupus erythematosus combined with pulmonary hypertension.
Time of Update: 2020-09-01
results of this study show that PAC is a good predictor of mortality and clinical deterioration in patients with systemic lupus-related pulmonary hypertension.
Take diet pills to take out pulmonary hypertension, how to treat this disease?
Time of Update: 2020-07-31
Guide: Pulmonary hypertension is abnormally dangerous, how to choose medication. a few days ago saw a post reported that a young woman had taken nearly 10 years of diet pills, this year due to the appearance of discomfort symptoms to go